Lori Lawley
2022
In 2022, Lori Lawley earned a total compensation of $692K as Chief Financial Officer at NewLink Genetics, a 15% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $170,476 |
|---|---|
| Option Awards | $85,444 |
| Salary | $389,923 |
| Stock Awards | $10,020 |
| Other | $36,166 |
| Total | $692,029 |
Lawley received $389.9K in salary, accounting for 56% of the total pay in 2022.
Lawley also received $170.5K in non-equity incentive plan, $85.4K in option awards, $10K in stock awards and $36.2K in other compensation.
Rankings
In 2022, Lori Lawley's compensation ranked 3,804th out of 5,759 executives tracked by ExecPay. In other words, Lawley earned more than 33.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,804 out of 5,759 | 34th |
Division Manufacturing | 2,153 out of 3,135 | 31st |
Major group Chemicals And Allied Products | 1,037 out of 1,421 | 27th |
Industry group Drugs | 973 out of 1,322 | 26th |
Industry Pharmaceutical Preparations | 712 out of 968 | 26th |
Source: SEC filing on March 31, 2023.
Lawley's colleagues
We found two more compensation records of executives who worked with Lori Lawley at NewLink Genetics in 2022.
News
NewLink Genetics CEO Richard Hawkins' 2023 pay falls 25% to $953K
April 12, 2024
NewLink Genetics CEO Richard Hawkins' 2022 pay slips 6% to $1.3M
March 31, 2023
NewLink Genetics CSO John McKew's 2021 pay rises 15% to $1.4M
March 23, 2022
NewLink Genetics CEO Richard Hawkins' 2020 pay jumps 200% to $2.2M
April 6, 2021